Evidence map›Paper›PMID 39280028›Full record

ArticleThe Lancet regional health. Western Pacific2024

Challenges or opportunities in developing clinical research in resource-limited regions? Insights from a province-wide survey of Chinese health professionals.

Hua Zheng, Fangfang Liu, Ji Ke, Guangli Qiao, Yanfu Wang, Ling Ma, Zhonghu He, Jinhan Lv, Yang Ke

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hua ZhengHealth Commission of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750004, PR China.
Fangfang LiuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, PR China.
Ji KeKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, PR China.
Guangli QiaoReproductive Health Technology Guidance Service Center of Health Commission of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750010, PR China.
Yanfu WangReproductive Health Technology Guidance Service Center of Health Commission of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750010, PR China.
Ling MaReproductive Health Technology Guidance Service Center of Health Commission of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750010, PR China.
Zhonghu HeState Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, PR China.
Jinhan LvHealth Commission of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750004, PR China.
Yang KeState Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39280028
PMCPMC11400987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.